Butylphthalide (Standard)
Butylphthalide (Standard) is the analytical standard of Butylphthalide. This product is intended for research and analytical applications. Butylphthalide (3-n-Butylphthalide) is an active molecule against cerebral ischemia. It was originally isolated from celery species and has been shown to be effective in stroke animal models.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 6066-49-5
- Formule: C12H14O2
- Masse moléculaire:190.24
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-B0647
ButylphthalideAntiplatelet/Antithrombotic Agent -
HY-122778
δ-TocotrienolVitamin E -
HY-N0188
Esculinp38 MAPK Inhibitor -
HY-B0558
CarbimazoleAntithyroid Agent -
HY-12511
SKF-86002p38 MAPK Inhibitor -
HY-W015445
SD-169p38α Inhibitor -
HY-N0188R
Esculin (Standard)p38 MAPK Inhibitor -
HY-122778R
δ-Tocotrienol (Standard)Vitamin E -
HY-B0558R
Carbimazole (Standard)Antithyroid Agent -
HY-12511R
SKF-86002 (Standard)p38 MAPK Inhibitor -
HY-108346
JX401p38 Inhibitor -
HY-W015445R
SD-169 (Standard)p38α Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 6066-49-5
-
Masse moléculaire 190.24
-
Formule C12H14O2
-
SMILES
O=C1OC(CCCC)C2=C1C=CC=C2
-
Synonyms
3-n-Butylphthalide (Standard); 3-Butylphthalide (Standard)
-
Structure Classification
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Cui LY, et al. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial. Chin Med J (Engl). 2013;126(18):3405-10. [Content Brief]
[2]. Zhao W, et al. 3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia. Neural Regen Res. 2014 Apr 1;9(7):719-26. [Content Brief]
[3]. Wang X, et al. Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents. Org Biomol Chem. 2014 Aug 21;12(31):5995-6004. [Content Brief]
[4]. Wang F, et al. Improvement of cognitive deficits in SAMP8 mice by 3-n-butylphthalide. Neurol Res. 2014 Mar;36(3):224-33. [Content Brief]
[5]. Chen XQ, Qiu K, Liu H, He Q, Bai JH, Lu W. Application and prospects of butylphthalide for the treatment of neurologic diseases. Chin Med J (Engl). 2019;132(12):1467-1477. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Butylphthalide (Standard) Related Classifications
HY-B0647R Related Classifications
Powered by Bioz